Showing results (2011-2020 of 2,134) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|October 1, 1991
Pharmacokinetics and bioavailability of papaverine HCl following intravenous, peroral, rectal, vaginal, topical and buccal administration in beagle dogsC Kraus, A Shaaya, J Ulmer, et al.Biopharmaceutics & Drug Disposition|April 1, 1985
Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose studyR Zaman, D B Jack, M R Wilkins, et al.Biopharmaceutics & Drug Disposition|April 1, 1985
Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of inputJ G Wagner, G J Szpunar, J J FerryBiopharmaceutics & Drug Disposition|November 7, 2022
Biodistribution and delivery of oligonucleotide therapeutics to the central nervous system: Advances, challenges, and future perspectivesAkihiko Goto, Syunsuke Yamamoto, Shinji IwasakiBiopharmaceutics & Drug Disposition|January 1, 1985
Comparison of nonlinear pharmacokinetic parameters estimated from the sinusoidal perfusion and venous equilibrium modelsJ G WagnerBiopharmaceutics & Drug Disposition|July 1, 1994
Influence of gamma-aminobutyric acid on baclofen intestinal absorptionA Nácher, A Polache, M J Moll-Navarro, et al.Biopharmaceutics & Drug Disposition|April 1, 1994
The effect of hepatic disease on the disposition of moricizine in humansH J Pieniaszek, A F Davidson, C M McEntegart, et al.Biopharmaceutics & Drug Disposition|January 20, 2024
Computational exploration of microsomal cytochrome P450 3A1 enzyme modulation by phytochemicals of Cichorium intybus L.: Insights into drug metabolismAbhishek Pathak, Satya Pal Singh, Dev Bukhsh Singh, et al.Biopharmaceutics & Drug Disposition|March 16, 2024
Characterization of AST-001 non-clinical pharmacokinetics: A novel selective AKR1C3-activated prodrug in mice, rats, and cynomolgus monkeysTeng Meng, Donald Jung, Xiao-Hong Cai, et al.Biopharmaceutics & Drug Disposition|July 20, 2024
Model-based interspecies interpretation of botulinum neurotoxin type A on muscle-contraction inhibitionHyo-Jeong Ryu, Seongsung Kwak, Misun Park, et al.Pageof 214